Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment
- 23 February 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 35 (3) , 647-654
- https://doi.org/10.1016/s0735-1097(99)00591-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Serum Total IGF-I, Free IGF-I, and IGFBP-1 Levels in an Elderly PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Insulin-Like Growth Factor-I, Insulin, and Angina Pectoris Secondary to Coronary Atherosclerosis, Vasospasm, and Syndrome XThe American Journal of Cardiology, 1997
- Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patientsThe Lancet, 1996
- Insulin-like growth factor-1 and angiographically documented coronary artery diseaseThe American Journal of Cardiology, 1996
- Insulin Resistance — Mechanisms, Syndromes, and ImplicationsNew England Journal of Medicine, 1991
- Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndromeDiabetologia, 1991
- Role of Insulin Resistance in Human DiseaseDiabetes, 1988
- Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitusJournal of Endocrinological Investigation, 1988
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985
- Nonketotic diabetes mellitus: Insulin deficiency or insulin resistance?The American Journal of Medicine, 1976